54 MGMT methylation assessed by methyl-BEAMing technique is a prognostic and predictive biomarker in glioblastoma and metastatic colorectal cancer patients — Ludovic Barault (2014) | RDL Network
54 MGMT methylation assessed by methyl-BEAMing technique is a prognostic and predictive biomarker in glioblastoma and metastatic colorectal cancer patients
Ludovic Barault, Alessio Amatu, Fonnet E. Bleeker, Cátia Moutinho, Chiara Falcomatà, Valentina Fiano, Andrea Cassingena, Giulia Siravegna, Massimo Milione, Paola Cassoni, Filippo de Braud, Roberta Rudà, Riccardo Soffietti, Tiziana Venesio, Alberto Bardelli, Pieter Wesseling, Philip C. De Witt Hamer, Filippo Pietrantonio, Salvatore Siena, Manel Esteller, Andrea Sartore‐Bianchi, Federica Di Nicolantonio
Carmen Balañá, Cristina Carrato, José Luis Ramírez, Andrés F. Cardona, Mireia Berdiel‐Acer, José Javier Sánchez, Miquel Tarón, C. Hostalot, Eva Musulen, Aurelio Ariza, Rafael Rosell
Vicenç Ruiz de Porras, Sara Bystrup, Sara Cabrero-de las Heras, Eva Musulen, Luís Palomero, M. Henar Alonso, Rocío Nieto, Diego Arango, Vı́ctor Moreno, Cristina Queralt, José Luís Manzano, Laura Layos, Cristina Bugés, Eva Martinez‐Balibrea
Discussion(0)
No comments yet. Be the first to comment.